Company: IMRX
Filing Date: 2025-09-08
Form Type: 424B3
Source: 0001104659-25-088317
Chunk: 10

Company: Immuneering Corp
Filing Date: 2025-09-08
Form: 424B3
Chunk 10
---
 shares of our Class A common stock were outstanding. The Pre-Funded Warrants are exercisable until such Warrant is exercised in full. The exercise price and number of shares of Class A common stock issuable upon exercise of the Pre-Funded Warrants may be adjusted in certain circumstances, including in the event of a stock dividend, a forward or reverse split of our shares of Class A common stock, and certain other events. However, the Pre-Funded Warrants will not be adjusted for issuances of Class A common stock at prices below their respective exercise prices. A holder of a Pre-Funded Warrant may exercise such Pre-Funded Warrant by delivery to the Company of a duly executed PDF copy (or e-mail attachment) of the notice of exercise form annexed to the Pre-Funded Warrant, or the Notice of Exercise, and accompanied by full payment of the exercise price for the number of warrants being exercised. Subject to limited exceptions, a holder of Pre-Funded Warrants will not have the right to exercise any portion of its Pre-Funded Warrants if the holder (together with such holder’s affiliates, and any persons acting as a group together with such holder or any of such holder’s affiliates) would beneficially own a number of shares of our Class A common stock in excess of 9.99% of the shares of our Class A common stock then outstanding after giving effect to such exercise, or the Pre-Funded Warrant Beneficial Ownership Limitation; provided, however, that upon notice to us, the holder may increase or decrease the Pre-Funded Warrant Beneficial Ownership Limitation, provided that in no event shall the Pre-Funded Warrant Beneficial Ownership Limitation exceed 19.99% and any increase in the Pre-Funded Warrant Beneficial Ownership Limitation will not be effective until 61 days following notice of such increase from the holder to us. The holders of the Pre-Funded Warrants must pay the exercise price in cash upon exercise of the Pre-Funded Warrants, unless such holders are utilizing the cashless exercise provision of the Pre-Funded Warrants. The Pre-Funded Warrants may be exercised (in the sole discretion of the holder), in whole or in part, at such time by means of a “cashless exercise” in which the holder of such Pre-Funded Warrants shall be entitled to receive that number of warrant shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

| (A) | =